68Ga SS 0120
Alternative Names: [68G]SS0120; G-68 SS0120; Gallium-68 SS 0120; SS-0120; SSO-120Latest Information Update: 22 Jul 2022
At a glance
- Originator Ariceum Therapeutics
- Class Imaging agents; Radiopharmaceutical diagnostics
- Mechanism of Action Radionuclide imaging enhancers
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Phase I Neuroblastoma; Solid tumours
Most Recent Events
- 21 Jul 2022 Phase-I clinical trials in Neuroblastoma (Diagnosis) in Germany (Parenteral) (Ariceum Therapeutics pipeline, July 2022)
- 21 Jul 2022 Phase-I clinical trials in Solid tumours (Diagnosis) in Germany (Parenteral) (Ariceum Therapeutics pipeline, July 2022)